Article(id=1325223713305658353, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223687443579685, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.03.017, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1756656000000, receivedDateStr=2025-09-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887554718, onlineDateStr=2026-11-05, pubDate=1773072000000, pubDateStr=2026-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887554718, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887554718, creator=13701087609, updateTime=1793887554718, updator=13701087609, issue=Issue{id=1325223687443579685, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='3', pageStart='213', pageEnd='340', issueExtLink='null', onlineDate='null', pubDate='1773072000000', pubDateStr='2026-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887548552, creator='13701087609', updateTime=1793934823634, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421973555257460, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223687443579685, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421973555257461, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223687443579685, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=332, endPage=340, ext={EN=ArticleExt(id=1325223713670562802, articleId=1325223713305658353, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress on the mechanism of chronic obstructive pulmonary disease based on the metabolic immune linkage, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Chronic obstructive pulmonary disease(COPD) is a globally prevalent chronic inflammatory airway disease, for which current clinical interventions remain limited in effectively halting its progression. In recent years, the metabolic-immune linkage has emerged as a critical breakthrough in elucidating COPD pathogenesis. This article reviewed research progress on lipid metabolic reprogramming, immune cell metabolic dependencies, and aberrant signaling pathways in COPD, with amphasis on the interplay between metabolic pathways-such as adenosine monophosphate-activated protein kinase, sirtuin 1, and peroxisome proliferator-activated receptor γ-with immune regulation, and assessed the current targeted therapeutic strategies and drug development, aiming to provide theoretical insights for future mechanistic studies and clinical translation, thereby broadening the landscape for precision therapy in COPD.

, authors=Jiahui WANG, Fenghua GU*, authorsList=Jiahui WANG, Fenghua GU, authorCompany=null, correspAuthors=Fenghua GU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223714081604595, articleId=1325223713305658353, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=基于代谢-免疫联动探讨慢性阻塞性肺疾病机制的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)作为全球高发的慢性气道炎症性疾病,当前临床治疗手段对其进展控制仍有限。近年来,代谢-免疫联动机制已成为解析COPD发病机制的重要突破口。该文综述COPD中脂质代谢重编程、免疫细胞代谢依赖性及关键信号通路异常的研究进展,重点聚焦腺苷酸活化蛋白激酶、沉默调节蛋白1及过氧化物酶体增殖物激活受体γ等代谢通路与免疫调节的交叉机制,并评估相关靶向干预策略及药物研究现状,以期为未来该领域机制研究及临床转化提供理论参考,从而拓展COPD精准治疗的思路及前景。

, authors=王佳慧, 顾丰华*, authorsList=王佳慧, 顾丰华, authorCompany=null, correspAuthors=顾丰华, authorNote=

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

, correspAuthorsNote=
顾丰华,硕士生导师,副教授,研究方向:呼吸系统疾病药物评价研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=a+eGAWynxsN9dpoCl1Dmsg==, magXml=VY4fGNPYWfZFd4vBVCH7nw==, pdfUrl=null, pdf=VdSlkWwZunwfw/AtwJJCKg==, pdfFileSize=970302, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=zKB+6zjYyTkr6Ee/tocIWw==, mapNumber=null, fund=null)}, authors=[Author(id=1325223844306363032, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223844394443418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844306363032, language=EN, stringName=Jiahui WANG, firstName=Jiahui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223844587381403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844306363032, language=CN, stringName=王佳慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

"}, bioImg=null, bioContent=

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223844197311124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, xref=null, ext=[AuthorCompanyExt(id=1325223844209894037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223844218282646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325223844683850397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223844776125087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844683850397, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223844868399776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844683850397, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223844197311124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, xref=null, ext=[AuthorCompanyExt(id=1325223844209894037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223844218282646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])], keywords=[Keyword(id=1325223845082309281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=EN, orderNo=1, keyword=chronic obstructive pulmonary disease), Keyword(id=1325223845178778274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=EN, orderNo=2, keyword=immune regulation), Keyword(id=1325223845262664355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=EN, orderNo=3, keyword=metabolomics), Keyword(id=1325223845354939044, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=EN, orderNo=4, keyword=immunometabolism), Keyword(id=1325223845501739685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=EN, orderNo=5, keyword=targeted therapy), Keyword(id=1325223845594014374, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=CN, orderNo=1, keyword=慢性阻塞性肺疾病), Keyword(id=1325223845673706151, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=CN, orderNo=2, keyword=免疫调控), Keyword(id=1325223845774369448, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=CN, orderNo=3, keyword=代谢组学), Keyword(id=1325223845849866921, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=CN, orderNo=4, keyword=免疫代谢), Keyword(id=1325223845937947306, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, language=CN, orderNo=5, keyword=靶向治疗)], refs=[Reference(id=1325223846135079595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CHRISTENSON SA. COPD Phenotyping[J]. Respir Care,2023, 68(7): 871-880., articleTitle=null, refAbstract=null), Reference(id=1325223846239937196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China[the China pulmonary health(CPH) study]: a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717., articleTitle=null, refAbstract=null), Reference(id=1325223846353183405, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=BOERS E, BARRETT M, SU JG, et al. Global burden of chronic obstructive pulmonary disease through 2050[J]. J Am Med Assoc Netw Open, 2023, 6(12): e2346598., articleTitle=null, refAbstract=null), Reference(id=1325223846441263790, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=FERRERA MC, LABAKI WW, HAN MK. Advances in chronic obstructive pulmonary disease[J]. Annu Rev Med,2021, 72: 119-134., articleTitle=null, refAbstract=null), Reference(id=1325223846546121391, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN H, LI Z, DONG L, et al. Lipid metabolism in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 1009-1018., articleTitle=null, refAbstract=null), Reference(id=1325223846613230256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LIPSON DA, BARNHART F, BREALEY N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD[J]. N Engl J Med, 2018, 378(18): 1671-1680., articleTitle=null, refAbstract=null), Reference(id=1325223846709699249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=O'NEILL LAJ, KISHTON RJ, RATHMELL J. A guide to immunometabolism for immunologists[J]. Nat Rev Immunol,2016, 16(9): 553-565., articleTitle=null, refAbstract=null), Reference(id=1325223846810362546, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=HOTAMISLIGIL GS. Foundations of immunometabolism and implications for metabolic health and disease[J].Immunity, 2017, 47(3): 406-420., articleTitle=null, refAbstract=null), Reference(id=1325223846881665715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=RIDOLO E, PUCCIARINI F, NIZI MC, et al. Mabs for treating asthma: omalizumab, mepolizumab, reslizumab,benralizumab, dupilumab[J]. Hum Vaccin Immunother,2020, 16(10): 2349-2356., articleTitle=null, refAbstract=null), Reference(id=1325223846978134708, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=GANESHAN K, CHAWLA A. Metabolic regulation of immune responses[J]. Annu Rev Immunol, 2014, 32: 609-634., articleTitle=null, refAbstract=null), Reference(id=1325223848676827829, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=XU W, DENG H, HU S, et al. Role of ferroptosis in lung diseases[J]. J Inflamm Res, 2021, 14: 2079-2090., articleTitle=null, refAbstract=null), Reference(id=1325223848886543030, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG Q, WANG Y, LI Z. Lipid metabolism reprogramming in chronic obstructive pulmonary disease[J]. Mol Med, 2025,31(1): 129., articleTitle=null, refAbstract=null), Reference(id=1325223848978817719, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAFIROVA-IVANOVSKA B, STOJKOVIKJ J, DOKIKJ D,et al. The level of cholesterol in COPD patients with severe and very severe stage of the disease[J]. Open Access Maced J Med Sci, 2016, 4(2): 277-282., articleTitle=null, refAbstract=null), Reference(id=1325223849071092409, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KOTLYAROV S, KOTLYAROVA A. Anti-inflammatory function of fatty acids and involvement of their metabolites in the resolution of inflammation in chronic obstructive pulmonary disease[J]. Int J Mol Sci, 2021, 22(23): 12803., articleTitle=null, refAbstract=null), Reference(id=1325223849188532922, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=YOSHIDA M, MINAGAWA S, ARAYA J, et al. Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis[J]. Nat Commun, 2019, 10(1): 3145., articleTitle=null, refAbstract=null), Reference(id=1325223849255641787, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=AGUDELO CW, SAMAHA G, GARCIA-ARCOS I. Alveolar lipids in pulmonary disease. A review[J]. Lipids Health Dis,2020, 19(1): 122., articleTitle=null, refAbstract=null), Reference(id=1325223849326944956, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=GRZELA K, LITWINIUK M, ZAGORSKA W, et al. Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9[J]. Arch Immunol Ther Exp(Warsz), 2016, 64(1): 47-55., articleTitle=null, refAbstract=null), Reference(id=1325223849410831037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=MINAGAWA S, YOSHIDA M, ARAYA J, et al. Regulated necrosis in pulmonary disease. a focus on necroptosis and ferroptosis[J]. Am J Respir Cell Mol Biol, 2020, 62(5): 554-562., articleTitle=null, refAbstract=null), Reference(id=1325223849498911422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=BARNES PJ, BAKER J, DONNELLY LE. Cellular senescence as a mechanism and target in chronic lung diseases[J]. Am J Respir Crit Care Med, 2019, 200(5): 556-564., articleTitle=null, refAbstract=null), Reference(id=1325223849641517760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=BARNES PJ. Oxidative stress-based therapeutics in COPD[J]. Redox Biol, 2020, 33: 101544., articleTitle=null, refAbstract=null), Reference(id=1325223849725403841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=LI CL, LIU JF, LIU SF. Mitochondrial dysfunction in chronic obstructive pulmonary disease: unraveling the molecular nexus[J]. Biomedicines, 2024, 12(4): 814., articleTitle=null, refAbstract=null), Reference(id=1325223849817678530, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU WC, QU J, XIE SY, et al. Mitochondrial dysfunction in chronic respiratory diseases: implications for the pathogenesis and potential therapeutics[J]. Oxid Med Cell Longev, 2021, 2021: 5188306., articleTitle=null, refAbstract=null), Reference(id=1325223849909953219, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=ANTUNES MA, LOPES-PACHECO M, ROCCO PRM.Oxidative stress-derived mitochondrial dysfunction in chronic obstructive pulmonary disease: a concise review[J]. Oxid Med Cell Longev, 2021, 2021: 6644002., articleTitle=null, refAbstract=null), Reference(id=1325223850014810820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=MIZUMURA K, GON Y. Iron-regulated reactive oxygen species production and programmed cell death in chronic obstructive pulmonary disease[J]. Antioxidants(Basel),2021, 10(10): 1569., articleTitle=null, refAbstract=null), Reference(id=1325223850107085509, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=POLVERINO F, WU TD, ROJAS-QUINTERO J, et al.Metformin: Experimental and clinical evidence for a potential role in emphysema treatment[J]. Am J Respir Crit Care Med,2021, 204(6): 651-666., articleTitle=null, refAbstract=null), Reference(id=1325223850199360198, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=DUFFNEY PF, FALSETTA ML, RACKOW AR, et al. Key roles for lipid mediators in the adaptive immune response[J].J Clin Invest, 2018, 128(7): 2724-2731., articleTitle=null, refAbstract=null), Reference(id=1325223850308412103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=JIN Y, TAKEDA Y, KONDO Y, et al. Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging[J]. Sci Rep, 2018, 8(1): 5145., articleTitle=null, refAbstract=null), Reference(id=1325223850392298184, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN S, SUMAN S, AMANN JM, et al. Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy[J]. Neoplasia, 2022, 32:100824., articleTitle=null, refAbstract=null), Reference(id=1325223850555876041, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=YASUDA H, YAMAYA M, NAKAYAMA K, et al. Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2005, 171(11): 1246-1251., articleTitle=null, refAbstract=null), Reference(id=1325223850639762122, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Q, WEI Y, WEI Y, et al. Erythromycin regulates peroxisome proliferator-activated receptor gamma to ameliorate cigarette smoke-induced oxidative stress in macrophages[J]. J Thorac Dis, 2024, 16(5): 3051-3060., articleTitle=null, refAbstract=null), Reference(id=1325223850753008331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=MICHAELOUDES C, BHAVSAR PK, MUMBY S, et al.Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases[J]. J Innate Immun,2020, 12(1): 31-46., articleTitle=null, refAbstract=null), Reference(id=1325223850862060236, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=HSIEH MH, CHEN PC, HSU HY, et al. Surfactant protein D inhibits lipid-laden foamy macrophages and lung inflammation in chronic obstructive pulmonary disease[J].Cell Mol Immunol, 2023, 20(1): 38-50., articleTitle=null, refAbstract=null), Reference(id=1325223850954334925, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=VOSS K, HONG HS, BADER JE, et al. A guide to interrogating immunometabolism[J]. Nat Rev Immunol,2021, 21(10): 637-652., articleTitle=null, refAbstract=null), Reference(id=1325223851042415310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=CAKMAK A, NEMUTLU E, YABANOGLU-CIFTCI S, et al. Metabolomic, oxidative, and inflammatory responses to acute exercise in chronic obstructive pulmonary disease[J]. Heart Lung, 2023, 59: 52-60., articleTitle=null, refAbstract=null), Reference(id=1325223851147272911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=RYAN EM, SADIKU P, COELHO P, et al. NRF2 Activation reprograms defects in oxidative metabolism to restore macrophage function in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2023, 207(8): 998-1011., articleTitle=null, refAbstract=null), Reference(id=1325223851235353296, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=TAKEDA Y, SUZUKI M, JIN Y, et al. Preventive role of tetraspanin CD9 in systemic inflammation of chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol, 2015, 53(6): 751-760., articleTitle=null, refAbstract=null), Reference(id=1325223851315045073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=PUCILLO C, VITALE G. Crossroads between immune responses and physiological regulation: metabolic control of resistance versus tolerance against disease[J]. Eur J Immunol, 2020, 50(4): 484-489., articleTitle=null, refAbstract=null), Reference(id=1325223851428291282, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=LOURENCO JD, ITO JT, de ARRUDA MARTINS M, et al. Th17/Treg Imbalance in chronic obstructive pulmonary disease: clinical and experimental evidence[J]. Front Immunol, 2021, 12: 804919., articleTitle=null, refAbstract=null), Reference(id=1325223851537343187, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=WHITE MJ, BEAVER CM, GOODIER MR, et al. Calorie restriction attenuates terminal differentiation of immune cells[J]. Front Immunol, 2017, 7: 667., articleTitle=null, refAbstract=null), Reference(id=1325223853269590740, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=KOBA T, TAKEDA Y, NARUMI R, et al. Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres[J]. ERJ Open Res,2021, 7(1): 00658-2020., articleTitle=null, refAbstract=null), Reference(id=1325223853391225557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU S, TAN X, LIU S. The role of extracellular vesicles in COPD and potential clinical value[J]. Respir Res, 2024,25(1): 84., articleTitle=null, refAbstract=null), Reference(id=1325223853496083158, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=PETRAROIA I, GHIDOTTI P, BERTOLINI G, et al.Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling[J].Cell Death Dis, 2023, 14(10): 681., articleTitle=null, refAbstract=null), Reference(id=1325223853605135063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S, VERMA SK, KUMAR S, et al. Evaluation of oxidative stress and antioxidant status in chronic obstructive pulmonary disease[J]. Scand J Immunol, 2017, 85(2): 130-137., articleTitle=null, refAbstract=null), Reference(id=1325223853697409752, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=SUL OJ, RA SW. Quercetin Prevents LPS-induced oxidative stress and inflammation by modulating NOX2/ROS/NF-kB in lung epithelial cells[J]. Molecules, 2021, 26(22): 6949., articleTitle=null, refAbstract=null), Reference(id=1325223853789684441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG XL, LI T, LI JH, et al. The Effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease[J]. Molecules, 2017, 22(9):1529., articleTitle=null, refAbstract=null), Reference(id=1325223853890347738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=LIAN N, ZHANG S, HUANG J, et al. Resveratrol attenuates intermittent hypoxia-induced lung injury by activating the Nrf2/ARE pathway[J]. Lung, 2020, 198(2): 323-331., articleTitle=null, refAbstract=null), Reference(id=1325223853999399643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=LI Q, ZHANG H, YAN X, et al. Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation[J]. Pulm Pharmacol Ther,2023, 79: 102197., articleTitle=null, refAbstract=null), Reference(id=1325223854108451548, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=BEIGOLI S, KIANI S, ASGHARZADEH F, et al. Promising role of peroxisome proliferator-activated receptors in respiratory disorders, a review[J]. Drug Metab Rev, 2025,57(1): 26-50., articleTitle=null, refAbstract=null), Reference(id=1325223854217503453, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU Q, CHEN Y, LIANG Y, et al. The role of lysophospholipid metabolites LPC and LPA in the pathogenesis of chronic obstructive pulmonary disease[J].Metabolites, 2024, 14(6): 317., articleTitle=null, refAbstract=null), Reference(id=1325223854355915486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=LOO CY, LEE WH. Nanotechnology-based therapeutics for targeting inflammatory lung diseases[J].Nanomedicine(Lond), 2022, 17(12): 865-879., articleTitle=null, refAbstract=null), Reference(id=1325223854473355999, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=PASSI M, SHAHID S, CHOCKALINGAM S, et al.Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases[J]. Int J Nanomedicine, 2020, 15:3803-3826., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325223844197311124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, xref=null, ext=[AuthorCompanyExt(id=1325223844209894037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223844218282646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.03.017, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.03.017, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.03.017, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.03.017, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1773072000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
基于代谢-免疫联动探讨慢性阻塞性肺疾病机制的研究进展
王佳慧 , 顾丰华 *
世界临床药物 | 综述评论 2026,47(3): 332-340
收起
收藏切换
世界临床药物 |综述评论 2026 , 47 (3) : 332 -340
基于代谢-免疫联动探讨慢性阻塞性肺疾病机制的研究进展
全屏
[Author(id=1325223844306363032, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223844394443418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844306363032, language=EN, stringName=Jiahui WANG, firstName=Jiahui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223844587381403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844306363032, language=CN, stringName=王佳慧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio={"content":"

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

"}, bioImg=null, bioContent=

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223844197311124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, xref=null, ext=[AuthorCompanyExt(id=1325223844209894037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223844218282646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])]), Author(id=1325223844683850397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223844776125087, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844683850397, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223844868399776, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, authorId=1325223844683850397, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223844197311124, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, xref=null, ext=[AuthorCompanyExt(id=1325223844209894037, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China), AuthorCompanyExt(id=1325223844218282646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223713305658353, companyId=1325223844197311124, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203)])])]
王佳慧, 顾丰华*
作者信息
  • 中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203
通讯作者:
顾丰华,硕士生导师,副教授,研究方向:呼吸系统疾病药物评价研究。
作者简介:

王佳慧,硕士研究生,研究方向:呼吸系统疾病药物评价研究。

Research progress on the mechanism of chronic obstructive pulmonary disease based on the metabolic immune linkage
Jiahui WANG, Fenghua GU*
Affiliations
  • National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai 201203, China
出版时间: 2026-03-10 doi: 10.13683/j.wph.2026.03.017
文章导航
收藏切换

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)作为全球高发的慢性气道炎症性疾病,当前临床治疗手段对其进展控制仍有限。近年来,代谢-免疫联动机制已成为解析COPD发病机制的重要突破口。该文综述COPD中脂质代谢重编程、免疫细胞代谢依赖性及关键信号通路异常的研究进展,重点聚焦腺苷酸活化蛋白激酶、沉默调节蛋白1及过氧化物酶体增殖物激活受体γ等代谢通路与免疫调节的交叉机制,并评估相关靶向干预策略及药物研究现状,以期为未来该领域机制研究及临床转化提供理论参考,从而拓展COPD精准治疗的思路及前景。

慢性阻塞性肺疾病  /  免疫调控  /  代谢组学  /  免疫代谢  /  靶向治疗

Chronic obstructive pulmonary disease(COPD) is a globally prevalent chronic inflammatory airway disease, for which current clinical interventions remain limited in effectively halting its progression. In recent years, the metabolic-immune linkage has emerged as a critical breakthrough in elucidating COPD pathogenesis. This article reviewed research progress on lipid metabolic reprogramming, immune cell metabolic dependencies, and aberrant signaling pathways in COPD, with amphasis on the interplay between metabolic pathways-such as adenosine monophosphate-activated protein kinase, sirtuin 1, and peroxisome proliferator-activated receptor γ-with immune regulation, and assessed the current targeted therapeutic strategies and drug development, aiming to provide theoretical insights for future mechanistic studies and clinical translation, thereby broadening the landscape for precision therapy in COPD.

chronic obstructive pulmonary disease  /  immune regulation  /  metabolomics  /  immunometabolism  /  targeted therapy
王佳慧, 顾丰华. 基于代谢-免疫联动探讨慢性阻塞性肺疾病机制的研究进展. 世界临床药物, 2026 , 47 (3) : 332 -340 . DOI: 10.13683/j.wph.2026.03.017
Jiahui WANG, Fenghua GU. Research progress on the mechanism of chronic obstructive pulmonary disease based on the metabolic immune linkage[J]. World Clinical Drug, 2026 , 47 (3) : 332 -340 . DOI: 10.13683/j.wph.2026.03.017

参考文献 引证文献
排序方式:
[1]
CHRISTENSON SA. COPD Phenotyping[J]. Respir Care,2023, 68(7): 871-880.
[2]
WANG C, XU J, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China[the China pulmonary health(CPH) study]: a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717.
[3]
BOERS E, BARRETT M, SU JG, et al. Global burden of chronic obstructive pulmonary disease through 2050[J]. J Am Med Assoc Netw Open, 2023, 6(12): e2346598.
[4]
FERRERA MC, LABAKI WW, HAN MK. Advances in chronic obstructive pulmonary disease[J]. Annu Rev Med,2021, 72: 119-134.
[5]
CHEN H, LI Z, DONG L, et al. Lipid metabolism in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14: 1009-1018.
[6]
LIPSON DA, BARNHART F, BREALEY N, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD[J]. N Engl J Med, 2018, 378(18): 1671-1680.
[7]
O'NEILL LAJ, KISHTON RJ, RATHMELL J. A guide to immunometabolism for immunologists[J]. Nat Rev Immunol,2016, 16(9): 553-565.
[8]
HOTAMISLIGIL GS. Foundations of immunometabolism and implications for metabolic health and disease[J].Immunity, 2017, 47(3): 406-420.
[9]
RIDOLO E, PUCCIARINI F, NIZI MC, et al. Mabs for treating asthma: omalizumab, mepolizumab, reslizumab,benralizumab, dupilumab[J]. Hum Vaccin Immunother,2020, 16(10): 2349-2356.
[10]
GANESHAN K, CHAWLA A. Metabolic regulation of immune responses[J]. Annu Rev Immunol, 2014, 32: 609-634.
[11]
XU W, DENG H, HU S, et al. Role of ferroptosis in lung diseases[J]. J Inflamm Res, 2021, 14: 2079-2090.
[12]
LIANG Q, WANG Y, LI Z. Lipid metabolism reprogramming in chronic obstructive pulmonary disease[J]. Mol Med, 2025,31(1): 129.
[13]
ZAFIROVA-IVANOVSKA B, STOJKOVIKJ J, DOKIKJ D,et al. The level of cholesterol in COPD patients with severe and very severe stage of the disease[J]. Open Access Maced J Med Sci, 2016, 4(2): 277-282.
[14]
KOTLYAROV S, KOTLYAROVA A. Anti-inflammatory function of fatty acids and involvement of their metabolites in the resolution of inflammation in chronic obstructive pulmonary disease[J]. Int J Mol Sci, 2021, 22(23): 12803.
[15]
YOSHIDA M, MINAGAWA S, ARAYA J, et al. Involvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesis[J]. Nat Commun, 2019, 10(1): 3145.
[16]
AGUDELO CW, SAMAHA G, GARCIA-ARCOS I. Alveolar lipids in pulmonary disease. A review[J]. Lipids Health Dis,2020, 19(1): 122.
[17]
GRZELA K, LITWINIUK M, ZAGORSKA W, et al. Airway remodeling in chronic obstructive pulmonary disease and asthma: the role of matrix metalloproteinase-9[J]. Arch Immunol Ther Exp(Warsz), 2016, 64(1): 47-55.
[18]
MINAGAWA S, YOSHIDA M, ARAYA J, et al. Regulated necrosis in pulmonary disease. a focus on necroptosis and ferroptosis[J]. Am J Respir Cell Mol Biol, 2020, 62(5): 554-562.
[19]
BARNES PJ, BAKER J, DONNELLY LE. Cellular senescence as a mechanism and target in chronic lung diseases[J]. Am J Respir Crit Care Med, 2019, 200(5): 556-564.
[20]
BARNES PJ. Oxidative stress-based therapeutics in COPD[J]. Redox Biol, 2020, 33: 101544.
[21]
LI CL, LIU JF, LIU SF. Mitochondrial dysfunction in chronic obstructive pulmonary disease: unraveling the molecular nexus[J]. Biomedicines, 2024, 12(4): 814.
[22]
ZHOU WC, QU J, XIE SY, et al. Mitochondrial dysfunction in chronic respiratory diseases: implications for the pathogenesis and potential therapeutics[J]. Oxid Med Cell Longev, 2021, 2021: 5188306.
[23]
ANTUNES MA, LOPES-PACHECO M, ROCCO PRM.Oxidative stress-derived mitochondrial dysfunction in chronic obstructive pulmonary disease: a concise review[J]. Oxid Med Cell Longev, 2021, 2021: 6644002.
[24]
MIZUMURA K, GON Y. Iron-regulated reactive oxygen species production and programmed cell death in chronic obstructive pulmonary disease[J]. Antioxidants(Basel),2021, 10(10): 1569.
[25]
POLVERINO F, WU TD, ROJAS-QUINTERO J, et al.Metformin: Experimental and clinical evidence for a potential role in emphysema treatment[J]. Am J Respir Crit Care Med,2021, 204(6): 651-666.
[26]
DUFFNEY PF, FALSETTA ML, RACKOW AR, et al. Key roles for lipid mediators in the adaptive immune response[J].J Clin Invest, 2018, 128(7): 2724-2731.
[27]
JIN Y, TAKEDA Y, KONDO Y, et al. Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging[J]. Sci Rep, 2018, 8(1): 5145.
[28]
GUAN S, SUMAN S, AMANN JM, et al. Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy[J]. Neoplasia, 2022, 32:100824.
[29]
YASUDA H, YAMAYA M, NAKAYAMA K, et al. Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2005, 171(11): 1246-1251.
[30]
LI Q, WEI Y, WEI Y, et al. Erythromycin regulates peroxisome proliferator-activated receptor gamma to ameliorate cigarette smoke-induced oxidative stress in macrophages[J]. J Thorac Dis, 2024, 16(5): 3051-3060.
[31]
MICHAELOUDES C, BHAVSAR PK, MUMBY S, et al.Role of metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases[J]. J Innate Immun,2020, 12(1): 31-46.
[32]
HSIEH MH, CHEN PC, HSU HY, et al. Surfactant protein D inhibits lipid-laden foamy macrophages and lung inflammation in chronic obstructive pulmonary disease[J].Cell Mol Immunol, 2023, 20(1): 38-50.
[33]
VOSS K, HONG HS, BADER JE, et al. A guide to interrogating immunometabolism[J]. Nat Rev Immunol,2021, 21(10): 637-652.
[34]
CAKMAK A, NEMUTLU E, YABANOGLU-CIFTCI S, et al. Metabolomic, oxidative, and inflammatory responses to acute exercise in chronic obstructive pulmonary disease[J]. Heart Lung, 2023, 59: 52-60.
[35]
RYAN EM, SADIKU P, COELHO P, et al. NRF2 Activation reprograms defects in oxidative metabolism to restore macrophage function in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2023, 207(8): 998-1011.
[36]
TAKEDA Y, SUZUKI M, JIN Y, et al. Preventive role of tetraspanin CD9 in systemic inflammation of chronic obstructive pulmonary disease[J]. Am J Respir Cell Mol Biol, 2015, 53(6): 751-760.
[37]
PUCILLO C, VITALE G. Crossroads between immune responses and physiological regulation: metabolic control of resistance versus tolerance against disease[J]. Eur J Immunol, 2020, 50(4): 484-489.
[38]
LOURENCO JD, ITO JT, de ARRUDA MARTINS M, et al. Th17/Treg Imbalance in chronic obstructive pulmonary disease: clinical and experimental evidence[J]. Front Immunol, 2021, 12: 804919.
[39]
WHITE MJ, BEAVER CM, GOODIER MR, et al. Calorie restriction attenuates terminal differentiation of immune cells[J]. Front Immunol, 2017, 7: 667.
[40]
KOBA T, TAKEDA Y, NARUMI R, et al. Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres[J]. ERJ Open Res,2021, 7(1): 00658-2020.
[41]
LIU S, TAN X, LIU S. The role of extracellular vesicles in COPD and potential clinical value[J]. Respir Res, 2024,25(1): 84.
[42]
PETRAROIA I, GHIDOTTI P, BERTOLINI G, et al.Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling[J].Cell Death Dis, 2023, 14(10): 681.
[43]
SINGH S, VERMA SK, KUMAR S, et al. Evaluation of oxidative stress and antioxidant status in chronic obstructive pulmonary disease[J]. Scand J Immunol, 2017, 85(2): 130-137.
[44]
SUL OJ, RA SW. Quercetin Prevents LPS-induced oxidative stress and inflammation by modulating NOX2/ROS/NF-kB in lung epithelial cells[J]. Molecules, 2021, 26(22): 6949.
[45]
WANG XL, LI T, LI JH, et al. The Effects of resveratrol on inflammation and oxidative stress in a rat model of chronic obstructive pulmonary disease[J]. Molecules, 2017, 22(9):1529.
[46]
LIAN N, ZHANG S, HUANG J, et al. Resveratrol attenuates intermittent hypoxia-induced lung injury by activating the Nrf2/ARE pathway[J]. Lung, 2020, 198(2): 323-331.
[47]
LI Q, ZHANG H, YAN X, et al. Up-regulation of PPAR-γ involved in the therapeutic effect of icariin on cigarette smoke-induced inflammation[J]. Pulm Pharmacol Ther,2023, 79: 102197.
[48]
BEIGOLI S, KIANI S, ASGHARZADEH F, et al. Promising role of peroxisome proliferator-activated receptors in respiratory disorders, a review[J]. Drug Metab Rev, 2025,57(1): 26-50.
[49]
ZHOU Q, CHEN Y, LIANG Y, et al. The role of lysophospholipid metabolites LPC and LPA in the pathogenesis of chronic obstructive pulmonary disease[J].Metabolites, 2024, 14(6): 317.
[50]
LOO CY, LEE WH. Nanotechnology-based therapeutics for targeting inflammatory lung diseases[J].Nanomedicine(Lond), 2022, 17(12): 865-879.
[51]
PASSI M, SHAHID S, CHOCKALINGAM S, et al.Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases[J]. Int J Nanomedicine, 2020, 15:3803-3826.
2026年第47卷第3期
57
8
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.03.017
  • 接收时间:2025-09-01
  • 首发时间:2026-11-05
  • 出版时间:2026-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-09-01
基金
作者信息
    中国医药工业研究总院,上海医药工业研究院有限公司,先导物成药性研究全国重点实验室,上海 201203

通讯作者:

顾丰华,硕士生导师,副教授,研究方向:呼吸系统疾病药物评价研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.03.017
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏